Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients
/in Dendritic Cells, International Publications, Malignant MelanomaImmunotherapy of acute myeloid leukemia: current approaches
/in Acute Leukemia, International PublicationsCostimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting
/in Dendritic Cells, International PublicationsPreliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium
/in Hyperthermia, International PublicationsCoordination of intratumoral immune reaction and human colorectal cancer recurrence
/in Colorectal Cancer, International PublicationsPromising novel immunotherapies and combinations for prostate cancer
/in International Publications, Prostate CancerCountering tumor-induced immunosuppression during immunotherapy for pancreatic cancer
/in International Publications, Pancreatic CancerGenetically engineered Newcastle disease virus for malignant melanoma therapy
/in International Publications, Malignant Melanoma, Newcastle Disease VirusStrong synergy of heat and modulated electromagnetic field in tumor cell killing
/in Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer